Welcome to Seagull Pharmacy!
Current Location:Home>Medical Information>Usage of Avirumab (Bavencio)
Usage of Avirumab (Bavencio)
Publisher:海鸥医学顾问     Publication Date:2025-09-16 17:27      The article comes from the Internet

The use of Bavencio involves preoperative pretreatment, standard infusion regimens, and adjustments for special populations, and must strictly follow indications and clinical norms. The following provides a detailed explanation from three aspects: medication process, dosage adjustment, and precautions.

1. Standard medication process

(1) Preoperative medication: Antihistamines and acetaminophen should be used for pre-treatment before the first 4 infusions, and whether to continue preoperative medication will be determined based on the infusion response.

(2) Infusion method: 800mg dose needs to be administered intravenously for 60 minutes, repeated every 2 weeks, using 20mg/mL clear solution.

2. Differences in indications and usage

(1) Single drug therapy: Merkel cell carcinoma and urothelial carcinoma are treated with simple intravenous infusion without the need for combination therapy with other drugs.

(2) Combination therapy: Renal cell carcinoma requires simultaneous oral administration of Axitinib 5mg twice daily, which can be taken with meals or on an empty stomach.

3 Special precautions

(1) Infusion monitoring: Observe allergic reactions throughout the entire process. If serious side effects occur, stop medication immediately and seek medical attention.

(2) Dosage preparation: Before use, check if the solution is clear and free of particles, and avoid shaking or dilution.

(3) Interval adjustment: If medication is delayed, the dosage should be replenished as soon as possible and the original cycle restored.

Disclaimer:《Usage of Avirumab (Bavencio)》Edited and sorted by Seagull Pharmacy's editors. Please contact us in time if there is any infringement. In addition, the suggestions for drug usage, dosage and disease mentioned in the article are only for medical staff's reference, and can not be used as any basis for medication!

Related Drugs

Bavencio

Full Name:

Reference Price:$10800.00

Prescribing Information: 阿维鲁单抗(Bavencio)是由辉瑞与德国默克公司联合研发的PD-L1免疫检查点抑制剂,2017年获FDA批准上市,成为全球首个治疗转移性默克尔细胞癌(MCC)的免疫疗法。 1.药品名称与主要成分‌ 通用名‌: 阿维鲁单抗(Avelumab) 商品名‌: B...